CHEK1 and neoplasm: Whilst the potential for Chk1 and Wee1 inhibitors to act as tumour radiosensitisers is compelling, there remain some uncertainties, and the mechanisms ultimately leading to cell death in the defined tumour cell models needs to be further investigated (Figure 3).